Reichert, Markus https://orcid.org/0000-0003-3290-0962
Brüßler, Sarah
Reinhard, Iris
Braun, Urs
Giurgiu, Marco https://orcid.org/0000-0001-6684-3463
Hoell, Andreas https://orcid.org/0000-0002-2725-046X
Zipf, Alexander https://orcid.org/0000-0003-4916-9838
Meyer-Lindenberg, Andreas https://orcid.org/0000-0001-5619-1123
Tost, Heike
Ebner-Priemer, Ulrich W.
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (2350/1)
Deutsche Forschungsgemeinschaft (TRR 265 project A04)
Deutsche Forschungsgemeinschaft (SFB 1158 project B04 grant TO 539/3-1)
Deutsche Forschungsgemeinschaft (GRK2350/1 (project B02))
Deutsche Forschungsgemeinschaft (1158 project B09)
Deutsche Forschungsgemeinschaft (TRR 265 project S02)
Deutsche Forschungsgemeinschaft (TRR 265 projects A04 and S02)
Bundesministerium für Bildung und Forschung (01EF1803A project WP3)
Bundesministerium für Bildung und Forschung (grant 01EF1803A)
Bundesministerium für Bildung und Forschung (grant 01EF1803A)
Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg (42-5400/136/1)
Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg (grant 42-5400/136/1 and 42-04HV.MED(16)/16/1)
Karlsruher Institut für Technologie (KIT)
Article History
Received: 19 November 2021
Accepted: 22 April 2022
First Online: 6 May 2022
Declarations
:
: UW Ebner-Priemer reports personal fees from Boehringer Ingelheim for consulting outside the submitted work. A Meyer-Lindenberg reports lecture fees from the Lundbeck International Foundation, Paul-Martini-Stiftung, Lilly Deutschland, Atheneum, Fama Public Relations, IDIBAPS, Janssen-Cilag, Hertie-Stiftung, Bodelschwingh-Klinik, Pfizer, Universität Freiburg, Schizophrenia Academy, Hong Kong Society of Biological Psychiatry, Spanish Society of Psychiatry, Italian Society of Biological Psychiatry, Reunions I Ciencia S.L. Brain Center Rudolf Magnus UMC Utrecht, Friedrich-Merz-Stiftung, and consultant fees from Boehringer Ingelheim, Elsevier, Brainsway, Lundbeck Int. Neuroscience Foundation, Lundbeck A/S, Sumitomo Dainippon Pharma Co., Academic Medical Center of the University of Amsterdam, Synapsis Foundation-Alzheimer Research Switzerland, IBS Center for Synaptic Brain Dysfunction, Blueprint Partnership, University of Cambridge, Deutsches Zentrum für Neurodegenerative Erkrankungen, Zürich University, Brain Mind Institute, L.E.K. Consulting, ICARE Schizophrenia, Science Advances, Fondation FondaMental, von Behring Röntgen Stiftung, The Wolfson Foundation, Sage Therapeutics outside the submitted work. M. Reichert, S. Brüßler, I. Reinhard, U. Braun, M. Giurgiu, A. Hoell, A. Zipf and H. Tost declare that they have no competing interests.
: Our study was approved by the Medical Ethics Committee of Heidelberg University, Germany. Parents gave written informed consent for their children, who received monetary compensation for their effort.